Honkanen E, Teppo A M, Meri S, Lehto T, Grönhagen-Riska C
4th Department of Medicine, University of Helsinki, Finland.
Nephrol Dial Transplant. 1994;9(11):1553-9.
Idiopathic membranous glomerulonephritis (iMGN) has previously been shown to be associated with urinary excretion of terminal complement complexes while increased urinary levels of cytokines have been reported in mesangial proliferative glomerulonephritis. In the present cross-sectional study urinary excretion of IL-1 beta, TNF-alpha, IL-6, and soluble C5b-9 (SC5b-9) was examined for 23 patients with iMGN, 16 patients with diabetic nephropathy (DNP), and 17 healthy subjects. IL-1 beta excretion (pg/mg crea) was significantly higher in iMGN patients (375, range 162-11,000) than in DNP patients (39, range 22-59, P < 0.001) or healthy controls (151, range 23-481, P < 0.001). TNF-alpha excretion rate (pg/mg crea) was clearly higher (38, range 21-700) in iMGN patients than in DNP patients (14, range 8-52, P < 0.001) or healthy subjects (11, range 7-26, P < 0.001). Median IL-6 excretion (pg/mg crea) was only marginally higher in iMGN patients (73, range 0-850) than in healthy subjects (64, range 3-158, P = 0.02) but significantly higher than in DNP patients (29, range 17-47, P < 0.001). No significant correlation with corresponding serum values was observed for urinary IL-6 or TNF-alpha excretion. Urinary IL-1 beta and TNF-alpha correlated with decreased renal function. Five of 23 patients showed progression of iMGN over a follow-up of 6 months. The excretion of all cytokines, TNF-alpha in particular, was significantly higher in patients with a progressive disease than in the other patients.(ABSTRACT TRUNCATED AT 250 WORDS)
特发性膜性肾小球肾炎(iMGN)先前已被证明与终末补体复合物的尿排泄有关,而在系膜增生性肾小球肾炎中已报道细胞因子的尿水平升高。在本横断面研究中,对23例iMGN患者、16例糖尿病肾病(DNP)患者和17名健康受试者检测了IL-1β、TNF-α、IL-6和可溶性C5b-9(SC5b-9)的尿排泄情况。iMGN患者的IL-1β排泄量(pg/mg肌酐)(375,范围162 - 11,000)显著高于DNP患者(39,范围22 - 59,P < 0.001)或健康对照(151,范围23 - 481,P < 0.001)。iMGN患者的TNF-α排泄率(pg/mg肌酐)明显更高(38,范围21 - 700),高于DNP患者(14,范围8 - 52,P < 0.001)或健康受试者(11,范围7 - 26,P < 0.001)。iMGN患者的IL-6排泄中位数(pg/mg肌酐)仅略高于健康受试者(73,范围0 - 850)(64,范围3 - 158,P = 0.02),但显著高于DNP患者(29,范围17 - 47,P < 0.001)。尿IL-6或TNF-α排泄与相应血清值无显著相关性。尿IL-1β和TNF-α与肾功能下降相关。23例患者中有5例在6个月的随访中iMGN病情进展。病情进展患者的所有细胞因子排泄量,尤其是TNF-α,显著高于其他患者。(摘要截断于250字)